Department of Animal Biosciences, University of Guelph, Guelph, ON, N1G 2W1, Canada.
Department of Population Medicine, Ontario Veterinary College, University of Guelph, Guelph, ON, N1G 2W1, Canada.
J Dairy Sci. 2022 Jan;105(1):281-300. doi: 10.3168/jds.2021-21018. Epub 2021 Oct 28.
The objective of this study was to investigate the effects of a milk byproduct-based starter pellet, high in lactose, on feed intakes, growth, and rumen development when calves were fed either a high or low level of milk. This was done by using a 2 × 2 factorial design, with 120 Holstein heifer calves randomly assigned to 1 of 2 milk treatments and 1 of 2 feed treatments upon enrollment at birth. Calves were either assigned to a low (LM) or high (HM) level of milk replacer by an automated milk-feeding system for individually-housed calves. The LM treatment calves were offered 6 L/d (150 g/L; 1.2 L, 5×/d), whereas HM treatment calves were offered 15 L/d (150 g/L; 3 L, 5×/d) of milk replacer. Calves were also assigned to a milk byproduct- (whey) based starter feed treatment (WF), or a grain-based starter ration (95% concentrate starter pellet, 5% chopped wheat straw) feed treatment (GF). All calves were offered their treatment feed starting on d 5, with water offered ad libitum from d 0. The WF treatment calves were offered 150 g/d of the milk byproduct-based pellet until they consumed the entirety for 2 out of 3 consecutive days. At this point, WF treatment calves received 150 g of the milk byproduct-based pellet top dressed onto the grain-based ration to allow for ad libitum feed consumption until weaned, when they only received the grain-based ration postweaning (d 64-77). Calves on the GF feed treatment received only the grain-based ration. All calves were gradually weaned from d 43 to 63. By design, calves on the HM treatment consumed greater levels of milk than LM treatment calves for the majority of the days in the preweaning phase (8.9 ± 0.11 vs. 5.5 ± 0.11 L/d; SE). Calves on the GF and WF treatments consumed similar amounts of milk in the preweaning phase (7.2 ± 0.11 vs. 7.2 ± 0.11 L/d); however, there was a milk and feed treatment interaction detected for milk consumption in the weaning phase, with HM-GF calves drinking more milk than the other treatments and HM-WF calves drinking more milk than both LM-GF and LM-WF calves. The WF treatment calves had greater solid feed intake during the preweaning phase than GF treatment calves, with no feed intake differences in the weaning or postweaning phases. The WF calves drank more water in the preweaning phase than GF calves. Average daily gain was similar throughout the study between the GF and WF treatment calves. Rumen physiological measures were all similar by the end of the trial (d 77) regardless of feed or milk treatment, suggesting similar rumen development postweaning. Overall, regardless of the level of milk fed, offering the milk byproduct-based starter pellet may increase preweaning feed intake, along with water consumption. However, both feed and milk treatments had similar performance and rumen development measures by the end of the trial.
本研究的目的是调查以乳糖为主要成分的牛奶副产品作为启动颗粒对小牛的采食量、生长和瘤胃发育的影响,研究采用 2×2 析因设计,120 头荷斯坦小母牛在出生时随机分配到 2 种牛奶处理和 2 种饲料处理中的 1 种。小牛要么通过自动牛奶喂养系统分配到低(LM)或高(HM)水平的牛奶代用品,要么分配到高(HM)或低(LM)水平的牛奶代用品。LM 处理组的小牛每天提供 6 L(150 g/L;1.2 L,5 次/d),而 HM 处理组的小牛每天提供 15 L(150 g/L;3 L,5 次/d)的牛奶代用品。小牛还被分配到牛奶副产品(乳清)为基础的启动饲料处理(WF)或谷物为基础的启动配合饲料处理(GF)。所有小牛从第 5 天开始喂食处理饲料,从第 0 天开始自由饮水。WF 处理组的小牛每天喂食 150 g 牛奶副产品基颗粒,直到连续 3 天中有 2 天吃完为止。此时,WF 处理组的小牛会在谷物基配合饲料上撒上 150 g 牛奶副产品基颗粒,让他们自由采食,直到断奶,断奶后(第 64-77 天)只给他们谷物基配合饲料。GF 饲料处理组的小牛只接受谷物基配合饲料。所有小牛从第 43 天到第 63 天逐渐断奶。设计上,HM 处理组的小牛在前断奶期的大部分时间里比 LM 处理组的小牛摄入更多的牛奶(8.9±0.11 vs. 5.5±0.11 L/d;SE)。GF 和 WF 处理组的小牛在前断奶期摄入的牛奶量相似(7.2±0.11 vs. 7.2±0.11 L/d);然而,在断奶期,牛奶和饲料处理之间存在交互作用,HM-GF 组的小牛比其他组的小牛摄入更多的牛奶,HM-WF 组的小牛比 LM-GF 和 LM-WF 组的小牛摄入更多的牛奶。WF 处理组的小牛在前断奶期的固体饲料采食量大于 GF 处理组的小牛,而在断奶和断奶后阶段没有饲料采食量差异。WF 组的小牛在前断奶期的饮水量大于 GF 组的小牛。在整个研究过程中,GF 和 WF 处理组的小牛的平均日增重相似。无论饲料或牛奶处理如何,到试验结束(第 77 天),瘤胃生理指标均相似,提示断奶后瘤胃发育相似。总体而言,无论喂养的牛奶水平如何,提供以乳糖为主要成分的牛奶副产品都可能增加断奶前的采食量和饮水量。然而,到试验结束时,饲料和牛奶处理都具有相似的性能和瘤胃发育指标。